메뉴 건너뛰기




Volumn 58, Issue 4, 2010, Pages 441-448

NYHA class II subgrouping: Correlation with left ventricular dysfunction questionnaire (LVD-36) and ejection fraction

Author keywords

Dyspnea; Ejection fraction; Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

EID: 78751664349     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (17)
  • 1
    • 78751666928 scopus 로고
    • 1929 The Heart Committee of the New York Tuberculosis and Health Association, Inc. 1 st, 2nd, 3rd eds. New York, NY: Paul B. Hoeber
    • The Heart Committee of the New York Tuberculosis and Health Association, Inc.: Criteria for the Classification and Diagnosis of Heart Disease, 1 st, 2nd, 3rd eds. New York, NY: Paul B. Hoeber; 1928, 1929, 1932.
    • (1928) Criteria for the Classification and Diagnosis of Heart Disease
  • 3
    • 0037137297 scopus 로고    scopus 로고
    • Heart Failure ET(A) Receptor Blockade Trial. Hemodynamic and neurohumoral effects of selective endothelin a (ET(A)) receptor blockade in chronic heart failure: The Heart Failure ET(A) Receptor Blockade Trail (HEAT)
    • Luscher TF, Enseleit F, Pacher R, Mitrovic V, Schulze MR, Willenbrock R et al. Heart Failure ET(A) Receptor Blockade Trial. Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trail (HEAT). Circulation 2002;106:2666-72.
    • (2002) Circulation , vol.106 , pp. 2666-2672
    • Luscher, T.F.1    Enseleit, F.2    Pacher, R.3    Mitrovic, V.4    Schulze, M.R.5    Willenbrock, R.6
  • 4
    • 0141595104 scopus 로고    scopus 로고
    • Sustained reduction of aldosterone in response to the angiotensin receptor blocker Valsartan in patients with chronic heart failure: Results from the Valsartan Heart Failure Trial
    • Cohn JN, Anand IS, Latini R, Masson S, Chiang YT, Glazer R et al. Sustained reduction of aldosterone in response to the angiotensin receptor blocker Valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial. Circulation 2003;108:1306-9.
    • (2003) Circulation , vol.108 , pp. 1306-1309
    • Cohn, J.N.1    Anand, I.S.2    Latini, R.3    Masson, S.4    Chiang, Y.T.5    Glazer, R.6
  • 5
    • 1842746203 scopus 로고    scopus 로고
    • Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II))
    • DOI 10.1007/s00392-003-0959-7
    • Bohm M, Maack C, Wehrlen-Garndjean M, Erdmann E. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac insufficiency Bisoprolol Study II [CIBIS II]). Z Kardiol 2003;92:668-76. (Pubitemid 37046723)
    • (2003) Zeitschrift fur Kardiologie , vol.92 , Issue.8 , pp. 668-676
    • Bohm, M.1    Maack, C.2    Wehrlen-Grandjean, M.3    Erdmann, E.4
  • 6
    • 10744233124 scopus 로고    scopus 로고
    • Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy
    • Adamopoulos S, Parissis JT, Paraskevaidis I, Karatzas D, Livanis E, Georgiadis M et al. Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2003;24:2186-96.
    • (2003) Eur Heart J , vol.24 , pp. 2186-2196
    • Adamopoulos, S.1    Parissis, J.T.2    Paraskevaidis, I.3    Karatzas, D.4    Livanis, E.5    Georgiadis, M.6
  • 7
    • 0842283181 scopus 로고    scopus 로고
    • Does aerobic training lead to a more active lifestyle and improved quality of life in patients with chronic heart failure?
    • Van den Berg-Emans R, Balk A, Bussmann H, Stam H. Does aerobic training lead to a more active lifestyle and improved quality of life in patients with chronic heart failure? Eur J Heart Fail 2004;6:95-100.
    • (2004) Eur J Heart Fail , vol.6 , pp. 95-100
    • Van Den Berg-Emans, R.1    Balk, A.2    Bussmann, H.3    Stam, H.4
  • 9
    • 0344430259 scopus 로고    scopus 로고
    • The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class patients with myocardial infarction and reduced left ventricular systolic function
    • TRACE Study Group
    • Abdulla J, Burchardt H, Albildstrom SZ, Kober L, Torp-Pedersen; TRACE Study Group. The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class patients with myocardial infarction and reduced left ventricular systolic function. Eur Heart J 2003;24:2116-22.
    • (2003) Eur Heart J , vol.24 , pp. 2116-2122
    • Abdulla, J.1    Burchardt, H.2    Albildstrom, S.Z.3    Kober, L.4    Torp-Pedersen5
  • 10
    • 1042302161 scopus 로고    scopus 로고
    • Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV - Efficacy and quality of life
    • Muller K, Gamba G, Jaquet F, Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV - efficacy and quality of life. Eur J Heart Fail 2003;6:793-801.
    • (2003) Eur J Heart Fail , vol.6 , pp. 793-801
    • Muller, K.1    Gamba, G.2    Jaquet, F.3    Hess, B.4
  • 12
    • 85044705213 scopus 로고    scopus 로고
    • Sympatomatic cardiac obstruction-pilot study of enalapril in aortic stenosis. Safety and efficacy of Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS)
    • Chockalingam A, Venkatesan S, Subramaniam T, Jagannathan V, Elangovan S, Alagesan R et al. Sympatomatic cardiac obstruction-pilot study of enalapril in aortic stenosis. Safety and efficacy of Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS). Am Heart J 2004;147:E19.
    • (2004) Am Heart J , vol.147
    • Chockalingam, A.1    Venkatesan, S.2    Subramaniam, T.3    Jagannathan, V.4    Elangovan, S.5    Alagesan, R.6
  • 14
    • 0034118798 scopus 로고    scopus 로고
    • The left ventricular dysfunction questionnaire (LVD-36): Reliability, validity, and responsiveness
    • O'Leary CJ, Jones PW. The left ventricular dysfunction questionnaire (LVD-36): reliability, validity, and responsiveness. Heart 2000;83:634-40.
    • (2000) Heart , vol.83 , pp. 634-640
    • O'Leary, C.J.1    Jones, P.W.2
  • 16
    • 53549085406 scopus 로고    scopus 로고
    • Heart Failure Association of the ESC (HFA); European Society of Intensive Care Medicine (ESICM). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.
    • European Society of Cardiology
    • European Society of Cardiology; Heart Failure Association of the ESC (HFA); European Society of Intensive Care Medicine (ESICM). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-89.
    • (2008) Eur J Heart Fail , vol.10 , pp. 933-989
  • 17
    • 34247364400 scopus 로고    scopus 로고
    • Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure
    • Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 2007;93:476-82.
    • (2007) Heart , vol.93 , pp. 476-482
    • Raphael, C.1    Briscoe, C.2    Davies, J.3    Ian Whinnett, Z.4    Manisty, C.5    Sutton, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.